The disease mechanisms associated with onset and secondary effects of rotavirus (RV) diarrhea remain to be determined and may not be identical. In this study, we investigated whether onset of RV diarrhea is associated with increased intestinal permeability and/or motility. To study the transit time, fluorescent fluorescein isothiocyanate (FITC)-dextran was given to RV-infected adult and infant mice. Intestinal motility was also studied with an opioid receptor agonist (loperamide) and a muscarinic receptor antagonist (atropine). To investigate whether RV increases permeability at the onset of diarrhea, fluorescent 4-and 10-kDa dextran doses were given to infected and noninfected mice, and fluorescence intensity was measured subsequently in serum. RV increased transit time in infant mice. Increased motility was detected at 24 h postinfection (h p.i.) and persisted up to 72 h p.i in pups. Both loperamide and atropine decreased intestinal motility and attenuated diarrhea. Analysis of passage of fluorescent dextran from the intestine into serum indicated unaffected intestinal permeability at the onset of diarrhea (24 to 48 h p.i.). We show that RV-induced diarrhea is associated with increased intestinal motility via an activation of the myenteric nerve plexus, which in turn stimulates muscarinic receptors on intestinal smooth muscles.
W
hile rotavirus (RV) is well established as a major cause of severe acute gastroenteritis in young children all over the world, the mechanisms behind diarrhea and vomiting are still largely unknown. The fluid loss due to diarrhea may be caused by several mechanisms (1, 2) . High concentrations of poorly absorbable compounds may create an osmotic force causing a loss of fluid across the intestinal epithelium (osmotic diarrhea). Secretory diarrhea is characterized by an overstimulation of the intestinal secretory capacity not coupled to an inhibition of fluid absorptive mechanisms. Furthermore, if the barrier function of the epithelium is compromised by loss of epithelial cells or disruption of the tight junction, hydrostatic pressure in blood and lymphatic vessels may cause water and electrolytes to accumulate in lumen (exudative diarrhea) (1) . In most types of diarrhea, more than one of these pathophysiological mechanisms are involved.
Several hypotheses have been forwarded to explain RV-induced diarrhea, including a functional role of the virus-encoded enterotoxin NSP4 (3) (4) (5) , malabsorption secondary to failing transport of electrolytes and/or glucose/amino acids (6) , villus ischemia (7) (8) (9) (10) , and stimulation of the enteric nervous system (ENS) (11) and of enterochromaffin (EC) cells (12) . At the cellular and tissue levels, a new understanding of the disease mechanisms is beginning to emerge (2) . Intestinal permeability and motility are the two physiological mechanisms most rarely investigated, but currently they are being implicated in diarrheal syndromes (2, 13) . Intestinal permeability has only rarely been investigated in humans infected with RV (14) . In the early 1980s, Stintzing and coworkers (15) assessed the intestinal permeability in young children with RV infection using polyethylene glycols (PEG) of different molecular weights, and a significantly low urinary recovery of PEG was noted. A similar observation was made in adults by Serrander and coworkers (16) . Moreover, Johansen et al. (17) found that children with acute RV infection excreted less PEG in their urine than healthy children and children with enteropathogenic Escherichia coli (EPEC) infections. In vitro studies, on the other hand, have shown that RV can increase the permeability of polarized human epithelial Caco-2 cells (18) , probably due to a reorganization of the tight junction proteins claudin-1, occludin, and ZO-1 (19) . Furthermore, the RV enterotoxin NSP4 induces paracellular leakage in polarized epithelial cells and prevents lateral targeting of ZO-1 (20) . In line with this, it has also been demonstrated in Ussing chamber experiments that the electrical tissue conductance is increased in RV-infected intestines (11, 21) .
Intestinal motility has only occasionally been studied during RV infection. It is well established that stimulating the vagal efferent nerves to the gut increases intestinal motility via a direct effect on the intestinal musculature and/or via an excitation of the intestinal cells of Cayal (22) . Atropine, the classical muscarinic receptor antagonist, can block these effects. It is also well known that naturally occurring opioids can be used as antidiarrheal agents, but their adverse central nervous effects make them undesirable as remedies. Loperamide, an opioid receptor agonist, differs from other similar drugs by binding predominantly to intestinal tissue, and when given orally, it gains almost no access to the central nervous system (CNS). Its antidiarrheal action is thought to result from diminished intestinal motility by interfering with the myenteric plexa (22, 23) . Furthermore, loperamide can inhibit intestinal secretion caused by bacterial enterotoxins (24, 25) . Regarding RV infections, Yamashiro and coworkers (26) found a significant effect of the stool score on days 3 to 5 of treatment. Meta-analyses confirmed that patients treated with loperamide are less likely to have diarrhea 24 h after treatment and present with a shorter duration of diarrhea and fewer stools than patients in the placebo group (27) .
Previous human permeability and motility studies have been performed at a time when children already have documented RV diarrhea. Thus, it has remained unresolved whether the effects on motility and permeability are early or late host responses following diarrhea rather than the actual cause of diarrhea onset.
The objective of this study was to investigate whether and how intestinal permeability and motility are altered at the onset of RV diarrhea. To address this issue, different-sized fluorescent dextran doses were given to RV-infected and noninfected adult and infant mice to determine both permeability and transit kinetics. Intestinal motility was also studied after administration of the opioid receptor agonist loperamide or the muscarinic receptor antagonist atropine. Our study gives an important new understanding of the mechanisms triggering diarrhea.
MATERIALS AND METHODS
Animals. RV-naive BALB/c, 8-week-old adults and 5-to 7-day-old infant mice (B&K Laboratories, Sollentuna, Sweden) were used. They were housed in standard cages with free access to food and water. Pregnant females were transferred to individual cages 1 week before the expected day of birth, and offspring remained with their mother during the experimental period. The animal ethics committee in Stockholm approved the experimental protocol (N291/010, N289/09).
Rotavirus infection and criteria for diarrhea. Mice (adults and infants) were orally infected with 10 l/animal (100ϫ the dose causing diarrhea in 50% of animals [DD 50 ]) of wild-type murine RV (EDIM strain) as previously described (28) . Only infant mice were examined for diarrhea, since adult mice have previously been shown not to develop diarrhea (29) . Adult mice were infected to investigate whether any changes in motility and permeability occur in the absence of diarrhea. Diarrhea was defined as a liquid yellow stool revealed by gentle abdominal palpation as described elsewhere (11, 30) . The percentage of mice with diarrhea was calculated as the number of pups with typical diarrheal stools (loose, yellow, liquid feces) divided by the total number of pups in the same group. Mice were confirmed to have diarrhea before being included in the treatment studies with loperamide and atropine.
Motility studies. In the motility experiments, adult (n ϭ 6 to 13 at each time point) and infant (n ϭ 5 to 13 at each time point) BALB/c mice received orally 10 l of 4-kDa FITC-dextran probe (FD-4; Sigma) at 6, 12, 24, 48, 72, and 96 h p.i. The probe was also given to noninfected mice. The adult mouse dose was 0.5 mg/mouse, and the infant mouse dose was 0.25 mg/mouse. FITC-dextran was dissolved in Milli-Q water, and the solutions were freshly prepared before each experiment. For time points of 24 h p.i. and later, diarrhea was confirmed in all infected infant mice that received the probe. After 30 min for adults and 15 min for infant mice, the animals were sacrificed and the whole intestines, from stomach to rectum, were used for determination of transit time by UV light measurement by taking photos using an FITC-specific filter (filter 520DF30; Bio-Rad) in a ChemiDoc system (ChemiDoc XRS; Bio-Rad). The front part of the main accumulating FITC-dextran was defined from the photo, and the software program Illustrator CS6 was used to more exactly measure the intestinal length and migration of the FITC-dextran probe.
Intestinal transit was calculated at different time points on how far the FITC-dextran probe has passed as a percentage of the entire length of the intestine, from the pylorus to the rectum. Motility experiments were performed on two different occasions.
Antidiarrheal drug experiments. Loperamide hydrochloride and atropine sulfate salt monohydrate were purchased from Sigma (loperamide, no. 34014; atropine, no. A0257) and dissolved in Milli-Q water. Loperamide (10 mg/kg) or atropine (6 mg/kg) was administered orally to adult and infant mice at 40 and 44 h p.i. Four hours after the second dose, at 48 h p.i., mice received 4-kDa FITC dextran and were then sacrificed after 15 (infant) and 30 (adult) min for determination of transit time. In infant mice the antidiarrheal effect of loperamide and atropine was checked at 4 h after the first dose and 4 h after the second dose (48 h p.i.) of treatment, a time point associated with severe diarrhea of almost all mice. In the loperamide experiment, mice also were checked for diarrhea on the following day and received a final dose of loperamide at 64 h p.i., the effect of which was investigated 4 h later.
Intestinal permeability studies. The transmural passage into the blood of fluorescent 10-and 4-kDa dextran was used to assess the barrier characteristics of infant and adult mice infected with RV from 6 up to 96 h p.i. compared to noninfected animals. The barrier properties were described in two ways: (i) by a permeability index equal to the ratio between the relative uptake of fluorescent 10-and 4-kDa dextran and (ii) by the fold increase in either marker compared to the basal value for noninfected animals. The values are given as fluorescence intensity (FI). The relative permeation of the 10-and 4-kDa probes was used to calculate a permeability index (R) through their relative fluorescence intensities, F 10 and F 4 in blood/serum, i.e., R ϭ F 10 /F 4 .
Briefly, RV-naive BALB/c mice, noninfected and RV infected, received orally a mixture of 4-kDa FITC-dextran (adult mouse dose of 2.5 mg/ mouse; infant mouse dose of 0.7 mg/mouse) and 10-kDa rhodaminedextran (adult dose, 5.0 mg/mouse; infant dose, 1.4 mg/mouse). The fluorescently conjugated dextran (4-kDa FITC-dextran; no. FD-4; SigmaAldrich) and R881 (10-kDa rhodamine-dextran [4-kDa FITC-dextran; no. FD-4; and 10-kDa rhodamine-dextran; no R881; Sigma-Aldrich]) was freshly prepared in Milli-Q water before use. Blood was collected in serum tubes (BD Microtainer tubes; no. 365951) 3 h after tracer administration and centrifuged for 5 min at 1,677 ϫ g. The serum was diluted 1/50 in Milli-Q water, and the fluorescence intensities of FITC (494/518 nm) and rhodamine (565/580 nm) were measured with a fluorescence spectrophotometer (LS-3B; Perkin-Elmer, Waltham, MA).
Histology. Specimens (0.5 cm) were taken from the duodenum, the middle part of the jejunum, and the lowest part of ileum from adult and infant mice, noninfected and infected, at 48 h p.i. The specimens were fixed in 4% phosphate-buffered formaldehyde (no. 02176; Histolab, Sweden) and then embedded in paraffin. From each specimen, sections of 5-m thickness were cut and placed onto glass slides (SuperFrost Plus Menzel no. 06400; Histolab, Sweden). The paraffin was removed through 2 steps of 5-min incubations in tissue clear solution (code 1466; Sakura, Tokyo, Japan), and the tissues were hydrated through a series of ethanol (EtOH) baths (99.5% EtOH twice for 5 min each, 95% EtOH for 5 min, 70% EtOH for 5 min) followed by a final step in phosphate-buffered saline (PBS). Slides were then stained with hematoxylin and eosin for 5 min, rinsed in tap water, and mounted with Pertex mounting medium (no. 00814; Histolab, Sweden) and a cover glass.
Statistical analysis. Data were analyzed with nonparametric twotailed Mann-Whitney test and Kruskal-Wallis test using Prism Software 5.0 (GraphPad, San Diego, CA) or Fisher's exact test. Values were considered significant at P Յ 0.05.
RESULTS

Rotavirus increases intestinal motility in adult and infant mice.
Alterations in intestinal transit/motility have been associated with several forms of gastrointestinal diseases, promoting the development of pharmaceutical drugs that attenuate intestinal motility. For RV infection it still remains unclear whether RV could increase intestinal transit and thereby contribute to diarrhea.
Therefore, to obtain a global view of the possible involvement of increased motility in RV diarrhea, we infected infant and adult mice with murine RV at 10 l/animal (100ϫ DD 50 diarrhea doses) and characterized the kinetics of intestinal transit of a 4-kDa FITC-dextran probe. We observed that the probe passed along the entire intestine within 15 min in infected infant mice at 48 h p.i., more rapidly than for noninfected mice (P Յ 0.001) (Fig. 1A and  B) . Interestingly, the peak of transit at 48 h p.i. coincided with the time of the most severe diarrhea symptoms in pups, as 12 out of 13 mice had diarrhea (Table 1) . RV infection in mice was confirmed by eosin and hematoxylin staining of tissue sections of different parts of the small intestine (Fig. 2) . The characteristic vacuolization of the epithelial cells was seen on villi but not in the crypts.
We next investigated whether adult mice, despite not responding with diarrhea following RV infection, have altered intestinal motility. Theoretically, RV infection could stimulate the myenteric plexus and motility in the absence of diarrhea (2) . Indeed, we found that the infection in adult mice did not resulted in increased intestinal motility, as determined by the transit of FITC-dextran (Fig. 1C) . However, a slight effect was found at 24 h p.i., a time point typically associated with onset of diarrhea in pups.
Atropine, a muscarinic receptor antagonist, attenuates rotavirus motility and diarrhea. The motility studies with atropine oral treatment, using a dose of 6 mg/kg, were performed as described in Materials and Methods. We observed a significant decrease of intestinal motility in infected infant and adult mice treated with atropine compared to nontreated mice at 48 h p.i. (Fig. 3A and B) . In noninfected infant mice, atropine had a modest effect on motility (Fig. 3A) . Since the effect of atropine was also observed in noninfected mice ( Fig. 3A and B) , it did not seem likely to be virus specific.
We also investigated whether atropine could attenuate RVinduced diarrhea in infant mice. Only mice with confirmed diarrhea were included, and atropine was given at 40 and 44 p.i. The 
0/2 0/2 0/2 0/2 0/2 effect of the 2 doses of atropine was evaluated at 48 h p.i. In the mock-treated group 6/7 still had diarrhea, in contrast to only 3/11 in the atropine-treated group (P Ͻ 0.05 by Fisher's exact test) ( Table 2 ). In summary, we conclude that the muscarinic receptor antagonist can attenuate the increased intestinal motility and reduce diarrhea.
Stimulation of -opioid receptors in the myenteric plexa attenuates rotavirus diarrhea and motility. To further address how RV affects intestinal motility, we treated infected mice with loperamide, an opioid receptor agonist known for its effect of attenuating intestinal motility by interfering with the myenteric plexa of the ENS. Infant and adult mice were treated with two doses of loperamide (10 mg/kg, orally, 10 l/mouse) at 40 and 44 h p.i. At 48 h p.i., mice were given 4-kDa FITC-dextran, and after 15 and 30 min in infant and adult mice, respectively, mice were sacrificed for intestinal transit analysis (n ϭ 5 to 13 in each group) (Fig. 4A to   C ). We observed a decrease in intestinal motility in RV-infected infant mice treated with loperamide compared to nontreated infected mice at 48 h p.i. (Fig. 4A and B) . The FITC-dextran probe was flushed from the untreated infected mice (Fig. 4A, line 4 ) but was delayed in loperamide-treated and infected mice (Fig. 4A, line  5) . Giving loperamide to noninfected infant mice had a modest effect on motility (Fig. 4B) . No significant effect on intestinal motility was observed in infected adult mice treated with loperamide compared to infected nontreated adults at 48 h p.i. (Fig. 4C ). The drug again had only modest effect on noninfected adult mice (Fig.  4C) . We conclude that opioid receptor agonists can attenuate the increased intestinal motility in RV-infected mice.
We next investigated whether loperamide could attenuate RVinduced diarrhea using the same experimental protocol as that in the transit studies, i.e., infant mice were given doses of loperamide at 40 and 44 h p.i. In the mock-treated group, 12/13 had diarrhea at 40 h p.i., which was maintained during the course of the experiment until termination at 68 h p.i. (Table 1) , and among infected mice 8/9 had diarrhea at 40 h p.i., before administration of loperamide (Table 1) . Only the 8 mice with confirmed diarrhea were included in the loperamide-treated group. After the first dose (40 h p.i.), none of them displayed diarrhea at 44 h p.i. (Table 1) , and they showed no sign of diarrhea following administration of a second dose (48 h p.i.). The effect of loperamide was highly significant (P Ͻ 0.01 by Fisher's exact test).
To study the pharmacological kinetics of loperamide, treated mice were also inspected 20 h after administration of the second dose (64 h p.i.), and surprisingly, 6/8 mice displayed diarrhea. When all eight mice once again were given a single dose of loperamide, only 2/8 mice exhibited diarrhea 4 h later (Table 1 ) (68 h p.i.), an effect that was statistically significant (P Ͻ 0.05 by Fisher's exact test). In summary, we conclude that the opioid receptor agonist loperamide can abolish diarrhea in a time-dependent manner in this RV animal model.
The intestinal permeability to 4-and 10-kDa dextran probes is unaffected at the onset (24 to 48 h p.i.) of rotavirus-induced diarrhea in mice.
The fluid loss in diarrhea most likely is multifactorial and may, in the case of RV infection, include disturbances in intestinal permeability. Previous human studies investigating intestinal barrier functions (15, 17) all were conducted at a time point at which subjects already had diarrhea. Thus, it remains unclear whether permeability changes are a late host response following diarrhea and/or the result of extensive lesions of the epithelia rather than the actual cause of diarrhea onset.
To address this issue, we orally administered 4-kDa FITC-dextran and 10-kDa rhodamine-dextran to infant and adult mice at 6, 12, 24, 48, 72, and 96 h p.i. Adult and infant animals were bled at 3 h after tracer administration to assess the transmural passage of the probes. The use of two different-sized probes allowed us to investigate in more detail whether the intestinal barrier was influenced by the RV infection. The plasma concentration of the two probes, as reflected in their optical densities, was estimated during the course of infection as a measure of their intestinal permeability. A ratio between the permeability of the two probes was also determined (Table 3) , as well as the change of permeability to either compound (fold increase) compared to the corresponding noninfected animal.
We found that infected infant, in contrast to adult, mice responded with a significant increase in permeability for both the 4-and 10-kDa probes at 6 and 12 h p.i. (P Ͻ 0.01; Mann-Whitney test). The increase for the 4-kDa probe ( Fig. 5A and B ) was particularly dramatic. In contrast, at 24 h p.i. and up to 96 h p.i., the permeability to the 4-kDa probe was attenuated compared to that of noninfected mice, and a transient peak for the 10-kDa probe was observed at 72 h p.i. The most important observation was that no increased permeability was observed for the 4-kDa or the 10-kDa probes at 24 or 48 h p.i. (Fig. 5A and B and Table 3 ), time points when mice exhibited diarrhea, enterocyte vacuolization (28) , and villus atrophy in the jejunum part of the small intestine ( Fig. 2A and B) . Intestinal lesions (vacuolization and atrophy) were also observed in the duodenum and ileum, as well as apically in the epithelium, but not in crypts. This suggests that these pathological changes were not sufficient to induce increased permeability for 4-and 10-kDa dextran probes. A reduced surface area should principally affect the permeability of the 10-and 4-kDa probes to the same extent and yield a parallel decline of either marker in the blood. However, if there is a perturbation of the junctional integrity, the paracellular uptake of the larger 10-kDa probe might be enhanced relative to the smaller 4-kDa probe (termed the 10-kDa/4-kDa ratio) (31) . In the early phase of infection, the 10-kDa/4-kDa ratio was balanced, based on a 20-fold increased for the 4-kDa probe and an 18-fold increased for the 10-kDa probe. However, a pronounced 11-fold increase in the 10-kDa/4-kDa ratio was observed at 24 h p.i and a 17.9-fold increase at 72 h p.i., caused by the significant tightening of the epithelium for the 4-kDa probe (Table 3) . Interestingly, at 48 h p.i., when the clinical signs of diarrhea are obvious, the 10-kDa/4-kDa ratio was 4.5 and was caused by the decreased permeability of the 10-kDa probe (Table 3) .
To get further insight into the mechanisms associated with the onset of diarrhea, we investigated whether adult infected mice not responding with diarrhea from the small intestine (28) had a perturbed intestinal barrier. Accordingly, a set of experiments identical to the infant mouse permeability studies was performed in adult mice. The permeability of the 4-kDa probe was decreased at time points 6, 12, and 24 h p.i. (Fig. 6A) . A limited permeability increase for the 4-kDa probe was observed at 48 and 72 h p.i. but did not reach statistical significance. Rather, there was a significantly reduced permeability at 24 and 96 h p.i. (P Ͻ 0.05; MannWhitney test) (Fig. 6A ). There were no clear changes observed in the intestinal permeability of the 10-kDa probe (Fig. 6B) except at 12 h p.i. (P Ͻ 0.05; Mann-Whitney test). The 10-kDa/4-kDa ratio was highest from 6 to 24 h p.i. and then at 96 h p.i. (Table 4) . It is interesting that the increased ratio before 48 h p.i. seemed to be due to reduction of permeability for the 4-kDa probe, while the uptake of the 10-kDa probe remained virtually unaffected.
DISCUSSION
Several disease mechanisms, such as malabsorption, altered permeability, motility disturbances, stimulation of enterochromaffin cells, activation of the ENS, and the RV NSP4 toxin, have been associated with fluid loss in RV diarrhea (2, 3, 5-8, 12, 13) . Some of these mechanisms may indeed occur after the onset of diarrhea rather than being the actual cause. In this study, we have investigated how intestinal transit (motility) and epithelial permeability are related to the onset of RV diarrhea. These two important disease-associated mechanisms have not been studied together in the early phase of RV diarrhea. Motility of the small intestine, as in all parts of the digestive tract, is controlled predominantly by excitatory and inhibitory signals from the ENS; however, they are modulated by inputs from the CNS, whereas intestinal secretion is controlled mainly by intrinsic nerves and in particular by the submucosal plexus (22) . The autonomic nervous system control of motility is exerted mainly via the release of acetylcholine and the effect on muscarinic receptors. Hence, it is possible to block this motor response by atropine, as also demonstrated in this study. Considering in vivo studies in several experimental models of acute diarrhea, atropine has failed to attenuate the rate of fluid secretion in the small intestine.
In the present study, gut motility was determined by studying the intestinal transit of the 4-kDa FITC-dextran probe in infant and adult mice. Interestingly, in infant mice, the onset of diarrhea occurred concomitantly with a high intestinal transit of FITCdextran at 48 h p.i. (Fig. 1A and B) . To get further insight into the pathophysiological mechanisms responsible for the increased mo- tility, we treated noninfected and RV-infected mice with the -opioid receptor agonist loperamide, attenuating the activity of the myenteric plexus (23) , and with atropine, blocking muscarinic receptors on smooth muscles. Loperamide differs from other opioid analogues, as it binds predominantly to intestinal tissue. Thus, when given orally it has virtually no access to the CNS. Loperamide is a widely used antidiarrheal agent, its effects being attributed to an inhibitory action on smooth muscle tone and peristalsis, attenuating both cholinergic and noncholinergic influences on intestinal smooth muscles (32, 33) . The effect of loperamide was not restricted to infant mice, as adult noninfected and infected mice responded with attenuated intestinal motility, strongly suggesting that the effect is not virus specific. The efficacy was very pronounced, since the diarrhea in infant mice was completely abolished in 8/8 mice 4 h after a single dose. When giving a second dose, it appeared that the effect was time dependent, since 6/8 mice exhibited diarrhea 20 h after the second dose. In humans, maximal plasma loperamide concentration is achieved within 3 to 5 h in humans (34) , which corresponds to the significant effect observed within 4 h in the mouse model. It has also been proposed that loperamide, apart from its inhibitory action on smooth muscle tone, also can stimulate absorption of fluid, electrolytes, and glucose; moreover, it can reverse the prostaglandin E 2 (PGE 2 ) and cholera toxin-induced secretion to absorption (24) . In previous studies, loperamide has been administered to individuals with ongoing diarrhea; therefore, the question of whether increased gut motility is associated with the onset of diarrhea or a systemic host response following diarrhea is still unresolved.
The effect of atropine on infected infant mice after 2 doses (6 mg/kg) at 40 and 44 h p.i. determined a clear reduction in motility as well as reduced diarrhea, where only 3/11 mice had diarrhea after atropine treatment compared to 6/7 in the mock-treated group.
In conclusion, our results obtained with atropine, the classical muscarinic receptor antagonist, and loperamide, a -opioid receptor agonist, clearly suggest that ENS is involved in the motility response to rotavirus infection. We found earlier that the fluid loss in RV diarrhea is at least partly induced by activation of the ENS (11) .
Adult mice were explored to determine whether motility changes were associated with water and electrolyte loss (i.e., diarrhea) from the small intestine or whether motility changes occurred independently of diarrhea. Previous studies have shown that the small intestine of infant mice (11, 35) but not adult mice (28) respond with electrolyte and water secretion (diarrhea) following infection with murine RV. In diarrhea-resistant adult mice there was a most modest increase of intestinal motility at 24 h p.i. (Fig. 1C) but no overall increased motility during the course of infection.
The participation of prostaglandins (PGs) in RV diarrhea may be another factor explaining the different time courses for secretion and motility. It has been shown that PGs are produced under the influence of microorganisms and have immune-modulatory, anti-inflammatory, as well as proinflammatory actions (36) . Moreover, they can stimulate water secretion (37) (38) (39) (40) , an effect that can be blocked by drugs attenuating nerve activity, such as hexamethonium, a nicotinic receptor blocker, or lidocaine, a local anesthetic (41) , indicating that nerves are involved. Loperamide is also a potent inhibitor of intestinal fluid secretion induced by PGE 2 and cholera toxin. In children with RV gastroenteritis, elevated levels of PGE 2 and PGF 2 in both plasma and stools have been found, and treatment with the COX inhibitor aspirin reduced the duration of diarrhea (26) . Moreover, intravenous infusion of PG causes abdominal cramps (42) , inhibits intestinal motility (43, 44) , and stimulates water secretion (24, 38, 45) . In addition, RV induces COX2 mRNA and secretion of PGE 2 already within 8 h p.i. (46) . These observations make it tempting to speculate that the decreased motility with remaining diarrhea 72 to 96 h p.i. is induced by increasing concentrations of PGs. The action of PGs on smooth muscles, whether they act directly on the muscle cells or modulate of the release of neurotransmitters (47), is not yet fully understood.
In several in vitro animal and human studies, both increased and decreased permeability have been reported. Regarding RV, only a few human studies have been done (15) (16) (17) ; all of these studies were conducted on children already infected with RV, and the time course for conceivable permeability changes was not studied.
The use of a combination of two markers of different sizes to measure changes in the small intestinal permeability has proved to be a sensitive and specific approach (16, 48) . Interestingly, infected infant mice responded with a significant increase in permeability for both probes at 6 and 12 h p.i. (Fig. 5A and B) , whereas adults showed an increase only for the 10-kDa probe at 12 h p.i. (Fig. 6A and B) . The increased permeability at 6 and 12 h p.i. was due to the administration of the fecal debris but was not associated with diarrhea or increased motility. Furthermore, oral administration of a 10% fecal suspension from uninfected animals did not result in diarrhea. An obvious conclusion from this unexpected observation is that increased permeability per se is not sufficient to cause diarrhea, since at these early time points mice do not have diarrhea. The onset of diarrhea (24 to 48 h p.i.) was not associated with increased permeability to the two dextran probes despite significant lytic lesions in the small intestine at 48 h p.i. (Fig. 2A  and B ). This conclusion is further supported by our observation that even adult mice have similar pathological lesions at the same time points but no diarrhea (28) . Apparently, RV-induced pathological lesions per se in the small intestine (Fig. 2) are not sufficient to account for permeability changes or electrolyte changes during RV infections. A similar observation was reported by Heyman and coworkers (49) , who studied transepithelial fluxes of horseradish peroxidase (HRP; molecular mass of about 44 kDa) from mucosa to serosa in EDIM-infected mice in an Ussing chamber. During RV diarrhea (days 2 to 8), no change in mucosal-toserosal permeability to HRP was observed. On the other hand, during convalescence (days 9 to 14), when virus was no longer present in the mucosa, there was a 10-fold increase in HRP transport. They concluded that RV causes a transient rise in the gut permeability during convalescence (49) . In agreement with this observation, we found a significant transient rise in permeability 72 h p.i. in both infant (P Ͻ 0.01; Mann-Whitney test) and adult mice.
In infant mice, the 10-kDa/4-kDa ratio was decreased early in infection, at 6 and 12 h p.i., and at 48 h p.i. This reduced ratio at the time of diarrhea was apparently due to a reduction of the penetration of the 10-kDa probe. A most interesting observation was that the 4-kDa probe had reduced uptake from 24 to 72 h p.i in infant mice compared to uninfected infant mice. A similar observation was obtained for the 10-kDa probe at 24 to 48 h p.i in infant mice. These characteristics likely reflect both the surface area absorption and the barrier properties of the different probes sizes as described by the 10-kDa/4-kDa ratio.
In conclusion, we show that RV-infected mice have increased intestinal motility at the onset of diarrhea, and this is not associated with any increased intestinal permeability. These new observations may contribute to a better understanding of the mechanisms involved in RV diarrhea.
